BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 34516275)

  • 41. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
    Paltiel AD; Schwartz JL
    Ann Intern Med; 2021 Nov; 174(11):1563-1571. PubMed ID: 34461034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
    Skowronski DM; Kaweski SE; Irvine MA; Chuang ESY; Kim S; Sabaiduc S; Reyes RC; Henry B; Sekirov I; Smolina K
    CMAJ; 2023 Oct; 195(42):E1427-E1439. PubMed ID: 37903524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.
    Jones JM; Manrique IM; Stone MS; Grebe E; Saa P; Germanio CD; Spencer BR; Notari E; Bravo M; Lanteri MC; Green V; Briggs-Hagen M; Coughlin MM; Stramer SL; Opsomer J; Busch MP
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(22):601-605. PubMed ID: 37262007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men's Conference - Illinois, June-July 2021.
    Matthias J; Patrick S; Wiringa A; Pullman A; Hinton S; Campos J; Belville T; Sinner Mph M; Buchanan TT; Sim B; Goldesberry KE
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1223-1227. PubMed ID: 34473681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 reinfection: a rapid systematic review of case reports and case series.
    Wang J; Kaperak C; Sato T; Sakuraba A
    J Investig Med; 2021 Aug; 69(6):1253-1255. PubMed ID: 34006572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.
    Brown CM; Vostok J; Johnson H; Burns M; Gharpure R; Sami S; Sabo RT; Hall N; Foreman A; Schubert PL; Gallagher GR; Fink T; Madoff LC; Gabriel SB; MacInnis B; Park DJ; Siddle KJ; Harik V; Arvidson D; Brock-Fisher T; Dunn M; Kearns A; Laney AS
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1059-1062. PubMed ID: 34351882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2-Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization.
    Ioannou GN; Green P; Fan VS; Dominitz JA; O'Hare AM; Backus LI; Locke E; Eastment MC; Osborne TF; Ioannou NG; Berry K
    JAMA Netw Open; 2021 Apr; 4(4):e214347. PubMed ID: 33822066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.
    CDC COVID-19 Vaccine Breakthrough Case Investigations Team
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):792-793. PubMed ID: 34043615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
    Xu S; Huang R; Sy LS; Glenn SC; Ryan DS; Morrissette K; Shay DK; Vazquez-Benitez G; Glanz JM; Klein NP; McClure D; Liles EG; Weintraub ES; Tseng HF; Qian L
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1520-1524. PubMed ID: 34710075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Source of information on COVID-19 vaccine and vaccine hesitancy among U.S. Medicare beneficiaries.
    Kim J; Kim Y; Li Y
    J Am Geriatr Soc; 2022 Mar; 70(3):677-680. PubMed ID: 34894409
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19 Case Age Distribution: Correction for Differential Testing by Age.
    Fisman DN; Greer AL; Brankston G; Hillmer M; O'Brien SF; Drews SJ; Tuite AR
    Ann Intern Med; 2021 Oct; 174(10):1430-1438. PubMed ID: 34399059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five reasons why COVID herd immunity is probably impossible.
    Aschwanden C
    Nature; 2021 Mar; 591(7851):520-522. PubMed ID: 33737753
    [No Abstract]   [Full Text] [Related]  

  • 57. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
    Reche PA
    Front Immunol; 2020; 11():586984. PubMed ID: 33178220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Six months of COVID vaccines: what 1.7 billion doses have taught scientists.
    Ledford H
    Nature; 2021 Jun; 594(7862):164-167. PubMed ID: 34089016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.